Page last updated: 2024-11-08
alanine and Congenital Immunodeficiency Disease
alanine has been researched along with Congenital Immunodeficiency Disease in 1 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with lymphoma and associated B-cell immunodeficiency." | 1.62 | Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient. ( Adams, M; Baang, JH; Bachman, MA; Lauring, AS; Manthei, DM; Martin, ET; Mirabelli, C; Smith, C; Valesano, AL; Washer, L; Wobus, CE, 2021) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Baang, JH | 1 |
| Smith, C | 1 |
| Mirabelli, C | 1 |
| Valesano, AL | 1 |
| Manthei, DM | 1 |
| Bachman, MA | 1 |
| Wobus, CE | 1 |
| Adams, M | 1 |
| Washer, L | 1 |
| Martin, ET | 1 |
| Lauring, AS | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness[NCT05172063] | | 30 participants (Anticipated) | Observational | 2022-01-31 | Not yet recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for alanine and Congenital Immunodeficiency Disease